North America Bioreactors Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Cell (Mammalian Cells, Bacterial Cells, Yeast Cells, and Others); Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy, and Others); Technology (Wave-Induced Motion SUB, Stirred SUB, Single-Use Bubble Column, Others); End User [Research and development organizations, Biopharma Manufacturers, and Contract Manufacturing Organizations (CMOs)] and Country
Market Introduction
Bioreactors are large vessels that are used to provide optimal conditions for the growth of microorganisms, as well as help them efficiently carry out biochemical processes. The reactors are more suitable for the biochemical processes such as fermentation and antibiotic development and production, wherein bacteria or yeast are used as inocula. These biochemical processescan either be aerobic or anaerobic. Bioreactors are commonly cylindrical in shape, ranging in capacities from liters to cubic meters, and are generally made of stainless steel. Bioreactors provide a controllable environment, in terms of pH, temperature, nutrient supply, and shear stress. These equipment are used in a variety of applications, such as production of biopharmaceuticals and tissue engineering products.
Get more information on this report : 
Market Overview and Dynamics
The North Americabioreactorsmarket is expected to reach US$ 2,102.75 Mnby 2027 from US$ 1,188.50 Mn in 2019. The market is anticipated to grow at a CAGR of 7.5 % during 20120–2027.The increasing adoption of single-use bioreactors and initiatives by governments, and rapid growth of pharmaceuticals and biotechnology industries, generating greater demand for bioreactor systems, are among thefactors driving the market in North America. However, the stringent regulatory framework restrains the market growth.
Key Market Segments
In terms of cell, the mammalian cell segment accounted for the largest share of the North America bioreactors market in 2019. In terms of molecule, the monoclonal antibodies held the largest share of the market by 2027.The wave-induced motion SUB segment accounted for the largest share of the North America bioreactors market, by technology, in 2019. In terms of enduser, in2019, the biopharma manufacturers segment held the most significant share of the market.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the North America bioreactorsmarket report are theWorld Health Organization (WHO), International Trade Administration (ITA), and Pharmaceutical Research and Manufacturers of America (PhRMA), among others.
Reasons to buy report
- It provides understanding of the North America, push to talk market landscape and identifies market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the North America push to talk market.
- It helps efficiently plan merger and acquisition, and partnership deals in the xx market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of market performance of various segments pertaining to the North America push to talk market.
- It provides market revenue forecast of the market based on various segments for the period from 2019 to 2027.
NORTH AMERICA BIOREACTORSMARKET SEGMENTATION
By Cell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
- Others
By Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
- Others
By Technology
- Wave-Induced Motion SUB
- Stirred SUB
- Single-Use Bubble Column
- Others
By End User
- Biopharma Manufacturers
- Research and Development Organizations
- Contract Manufacturing Organizations (CMOs)
By Country
- US
- Canada
- Mexico
Company Profiles
- Thermo Fisher Scientific Inc.
- Pall Corporation
- PBS Biotech, Inc
- General Electric Company
- MERCK KGaA
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Bioreactors Market – By Cell
1.3.2 North America Bioreactors Market – By Molecule
1.3.3 North America Bioreactors Market – By Technology
1.3.4 North America Bioreactors Market– By End User
1.3.5 North America Bioreactors Market – By Country
2. North America Bioreactors Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Bioreactors Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Bioreactors Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Bioreactors Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Single-Use Bioreactors
5.1.2 Increasing Demand of Bioreactors by Biopharmaceutical and Biotechnology Companies
5.2 Key Market Restraints
5.2.1 Stringent Regulatory Framework
5.3 Key Market Opportunities
5.3.1 Rising Demand of Personalized Medicine
5.4 Future Trends
5.4.1 Technological Advancements in Bioreactors
5.5 Impact Analysis
6. Bioreactors Market – North America Analysis
6.1 North America Bioreactors Market Revenue Forecasts and Analysis
7. North America Bioreactors Market Analysis and Forecasts To 2027 – By Cell
7.1 Overview
7.2 North America Bioreactors market, By Cell 2019 & 2027 (%)
7.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Cell (US$ Mn)
7.3 Mammalian Cells
7.3.1 Overview
7.3.2 North America Mammalian Cells Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Bacterial Cells
7.4.1 Overview
7.4.2 North America Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Yeast Cells
7.5.1 Overview
7.5.2 North America Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
8. North America Bioreactors Market Analysis – By Molecule
8.1 Overview
8.2 North America Bioreactors Market, By Molecule 2019-2027 (%)
8.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Molecule (US$ Mn)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Vaccines
8.4.1 Overview
8.4.2 North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Recombinant Proteins
8.5.1 Overview
8.5.2 North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Stem Cells
8.6.1 Overview
8.6.2 North America Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Gene Therapy
8.7.1 Overview
8.7.2 North America Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Bioreactors Market Analysis – By Technology
9.1 Overview
9.2 North America Bioreactors Market, By Technology 2019-2027 (%)
9.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By Technology (US$ Mn)
9.3 Wave-Induced Motion SUB
9.3.1 Overview
9.3.2 North America Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Stirred SUB
9.4.1 Overview
9.4.2 North America Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Single-Use Bubble Column
9.5.1 Overview
9.5.2 North America Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Other Technologies
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. North America Bioreactors Market Analysis – By End-User
10.1 Overview
10.2 North America Bioreactors Market, By End-User 2019-2027 (%)
10.2.1 North America Bioreactors Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Research and Development Organizations
10.3.1 Overview
10.3.2 North America Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Biopharma Manufacturers
10.4.1 Overview
10.4.2 North America Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Contract Manufacturing Organisations (CMOs)
10.5.1 Overview
10.5.2 North America Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
11. Bioreactors Market Revenue and Forecasts To 2027 – Geographical Analysis
11.1 North America Bioreactors Market Revenue and Forecasts To 2027
11.1.1 Overview
11.1.2 North America Bioreactors Market Revenue And Forecasts to 2027 (US$ Mn)
11.1.3 North America Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.4 North America Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.5 North America Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.6 North America Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: Bioreactors Market, by Country, 2019 & 2027 (%)
11.1.7.1 US: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.1 US: Bioreactors Market- Revenue and Forecasts to 2027 (USD Million)
11.1.7.1.2 US Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.3 US Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.4 US Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.1.5 US Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7.2 Canada: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.1 Canada: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.2 Canada Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.3 Canada Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.4 Canada Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.2.5 Canada Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.1.7.3 Mexico: Bioreactors Market – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.1 Mexico Bioreactors Market Revenue and Forecasts to 2027 (USD Million)
11.1.7.3.2 Mexico Bioreactors Market, by Cell – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.3 Mexico Bioreactors Market, by Molecule – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.4 Mexico Bioreactors Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.1.7.3.5 Mexico Bioreactors Market, by End User – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic on North America Bioreactors Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. COMPANY PROFILES
13.1 Thermo Fisher Scientific Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pall Corporation
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 PBS Biotech, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 General Electric Company
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 MERCK KGaA
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Bioreactors Market Revenue and Forecasts To 2027, By Cell (US$ Mn)
Table 2. North America Bioreactors Market Revenue and Forecasts To 2027, By Molecule (US$ Mn)
Table 3. North America Bioreactors Market Revenue and Forecasts To 2027, By Technology (US$ Mn)
Table 4. North America Bioreactors Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. North America Bioreactors Market, By Cell– Revenue And Forecast To 2027
Table 6. North America Bioreactors Market Revenue And Forecasts To 2027, By Molecule (Us$ Million)
Table 7. North America Bioreactor Market Revenue And Forecasts To 2027, By Technology (US$ Million)
Table 8. North America Bioreactors Market Revenue And Forecasts To 2027, By End User (US$ Million)
Table 9. US Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 10. US Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 11. US Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 12. US Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 13. Canada Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 14. Canada Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 15. Canada Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 16. Canada Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 17. Mexico Bioreactors Market, By Cell – Revenue And Forecast To 2027 (USD Million)
Table 18. Mexico Bioreactors Market, By Molecule – Revenue And Forecast To 2027 (USD Million)
Table 19. Mexico Bioreactors Market, By Technology – Revenue And Forecast To 2027 (USD Million)
Table 20. Mexico Bioreactors Market, By End User – Revenue And Forecast To 2027 (USD Million)
Table 21. Glossary of Terms, Bioreactors Market
LIST OF FIGURES
Figure 1. Bioreactors Market Segmentation
Figure 2. North America Bioreactors Market Overview
Figure 3. Mammalian Cells Segment Held Largest Share of Cell in Bioreactors Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Bioreactors Market - Leading Country Markets (US$ Mn)
Figure 6. Bioreactors Market - North America PEST Analysis
Figure 7. Bioreactors Market Impact Analysis of Driver and Restraints
Figure 8. North America Bioreactors market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Bioreactors market, By Cell 2019 & 2027 (%)
Figure 10. North America Mammalian Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Bacterial Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Yeast Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Others Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Bioreactors Market, by Molecule 2019 & 2027 (%)
Figure 15. North America Monoclonal Antibodies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Recombinant Proteins Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Stem Cells Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Gene Therapy Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Bioreactors Market, by Technology 2019 & 2027 (%)
Figure 22. North America Wave-Induced Motion SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Stirred SUB Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Single-Use Bubble Column Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Bioreactors Market, by End-User 2019 & 2027 (%)
Figure 27. North America Research and Development Organizations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. North America Biopharma Manufacturers Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. North America Contract Manufacturing Organisations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America: Bioreactors Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. North America Bioreactors Market Revenue And Forecasts to 2027 (US$ Million)
Figure 32. North America: Bioreactors Market, By Country, 2019 & 2027 (%)
Figure 33. US: Bioreactors Market- Revenue And Forecasts to 2027 (USD Million)
Figure 34. Canada Bioreactors Market Revenue And Forecasts To 2027 (USD Million)
Figure 35. Mexico: Bioreactors Market – Revenue And Forecast To 2027 (USD Million)
Figure 36. Impact Of Covid-19 Pandemic In North American Country Markets
The List of Companies - North America Bioreactors Market
- Thermo Fisher Scientific Inc
- Pall Corporation
- PBS Biotech,Inc
- General Electric Company
- MERCK KGaA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North AmericaBioreactors Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.